November 13th 2024
Decisions and strategies related to remote work, AI, and DE&I are especially evolving.
Amryt Pharma: Realizing Rare Disease Treatments
June 19th 2018Pharm Exec speaks with Joe Wiley, CEO of Amryt Pharma, who is steering a road-less-traveled path for a small pharma-building a sustainable, commercial infrastructure first, with the hopes of accelerating new rare disease drugs to the market.
Organizational Design and Talent Strategy in the Changing Biopharma Landscape
April 6th 2018Without considering the organizational and talent aspects of change, companies put themselves at risk for poor employee engagement, loss of talent, and ultimately, failed business initiatives, writes Viq Prevaaz.